Literature DB >> 1734802

Systemic and regional hemodynamics of isoflurane and sevoflurane in rats.

P F Conzen1, B Vollmar, H Habazettl, E J Frink, K Peter, K Messmer.   

Abstract

The authors studied the effects of sevoflurane and isoflurane on systemic hemodynamics and regional blood flow distribution (microsphere technique) in 15 rats during general anesthesia with intravenous chloralose and controlled ventilation. Inhaled anesthetics were applied to reduce mean arterial blood pressure (MAP) to 70 mm Hg (1.66 vol% sevoflurane and 0.96 vol% isoflurane) and 50 mm Hg (MAP 50; 3.95 vol% sevoflurane and 2.43 vol% isoflurane). Control recordings were obtained with intravenous chloralose only. At a MAP of 70 mm Hg, both anesthetics reduced heart rate, cardiac output, and systemic vascular resistance to a similar degree. Isoflurane decreased systemic vascular resistance markedly at a MAP of 50 mm Hg and thereby maintained cardiac output at higher levels than sevoflurane. The left ventricular rate-pressure product decreased comparably with both anesthetics. Cerebral blood flow increased dose-dependently with both inhaled anesthetics but to a greater degree with isoflurane. Total hepatic blood flow remained unchanged from control at a MAP of 70 mm Hg but decreased at a MAP of 50 mm Hg. This was due to reductions of hepatic arterial and portal venous tributaries. Renal blood flow was reduced with only the high concentrations of the anesthetics. Myocardial blood flow was reduced at all concentrations of volatile anesthetic; however, the decrease was less with isoflurane. This would indicate a more pronounced coronary vasodilation by isoflurane as the rate-pressure product, as a measure of the actual left ventricular oxygen demand, decreased by comparable degrees with both anesthetics. Our results indicate that sevoflurane and isoflurane (each approximately 0.7 MAC) have no dissimilar systemic and regional hemodynamic effects at a MAP of 70 mm Hg in this animal model. At higher concentrations (approximately 1.7 MAC), cerebral blood flow was more with isoflurane than with sevoflurane and was associated with a more pronounced vasodilation in the myocardium.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734802     DOI: 10.1213/00000539-199201000-00014

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  30 in total

1.  Attenuation of ischemia-reperfusion injury by sevoflurane postconditioning involves protein kinase B and glycogen synthase kinase 3 beta activation in isolated rat hearts.

Authors:  Neng-Xin Fang; Yun-Tai Yao; Chun-Xia Shi; Li-Huan Li
Journal:  Mol Biol Rep       Date:  2010-03-10       Impact factor: 2.316

2.  Physiological modeling for indirect evaluation of drug tissular pharmacokinetics under non-steady-state conditions: an example of antimicrobial prophylaxis during liver surgery.

Authors:  Franck Lagneau; Jean Marty; Pascale Beyne; Michel Tod
Journal:  J Pharmacokinet Pharmacodyn       Date:  2005-02       Impact factor: 2.745

3.  Differential effects of halothane, enflurane, isoflurane, and sevoflurane on the hemodynamics and metabolism in the perfused rat liver in fasted rats.

Authors:  M Araki; H Inaba; T Mizuguchi
Journal:  J Anesth       Date:  1995-03       Impact factor: 2.078

4.  Use of sevoflurane inhalation sedation for outpatient third molar surgery.

Authors:  S Ganzberg; J Weaver; F M Beck; G McCaffrey
Journal:  Anesth Prog       Date:  1999

5.  Effects and interaction of nicardipine and volatile anesthetics in the rat heart-lung preparation.

Authors:  Satoshi Kashimoto; Toshihiro Nakamura; Masaki Kume; Akihiko Nonaka; Teruo Kumazawa
Journal:  J Anesth       Date:  1994-03       Impact factor: 2.078

6.  The effects of isoflurane and sevoflurane on the left ventricular end-systolic pressure-volume relation in dogs.

Authors:  Sumio Hoka; Michiko Sato; Shosuke Takahashi
Journal:  J Anesth       Date:  1995-09       Impact factor: 2.078

Review 7.  [Main determinants of liver microcirculation during systemic inflammation].

Authors:  C Wunder; N Roewer; O Eichelbrönner
Journal:  Anaesthesist       Date:  2004-11       Impact factor: 1.041

Review 8.  Sevoflurane. A review of its pharmacodynamic and pharmacokinetic properties and its clinical use in general anaesthesia.

Authors:  S S Patel; K L Goa
Journal:  Drugs       Date:  1996-04       Impact factor: 9.546

9.  Comparison of the direct effects of sevoflurane, isoflurane and halothane on isolated canine coronary arteries.

Authors:  K Nakamura; H Toda; Y Hatano; K Mori
Journal:  Can J Anaesth       Date:  1993-03       Impact factor: 5.063

10.  Effects of sevoflurane on self-renewal capacity and differentiation of cultured neural stem cells.

Authors:  Huang Nie; Zhengwu Peng; Ning Lao; Hailong Dong; Lize Xiong
Journal:  Neurochem Res       Date:  2013-06-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.